Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC) is widely acknowledged to be extremely sensitive to immunotherapy, emphasizing the tremendous impacts on which the tumor microenvironment (TME) has shown. However, the molecular subgroups characterized by the TME features scarcely serve as the risk stratificat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lu Zhang, Jianlong Li, Mengzhao Zhang, Lu Wang, Tao Yang, Qiuya Shao, Xiao Liang, Minghai Ma, Nan Zhang, Minxuan Jing, Rundong Song, Jinhai Fan
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/fca34c9ea4894a53b07da0f527e1a895
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fca34c9ea4894a53b07da0f527e1a895
record_format dspace
spelling oai:doaj.org-article:fca34c9ea4894a53b07da0f527e1a8952021-11-18T08:14:00ZIdentification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma1664-802110.3389/fgene.2021.722421https://doaj.org/article/fca34c9ea4894a53b07da0f527e1a8952021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fgene.2021.722421/fullhttps://doaj.org/toc/1664-8021Clear cell renal cell carcinoma (ccRCC) is widely acknowledged to be extremely sensitive to immunotherapy, emphasizing the tremendous impacts on which the tumor microenvironment (TME) has shown. However, the molecular subgroups characterized by the TME features scarcely serve as the risk stratification guides in clinical practice for survival outcomes and immunotherapy response prediction. This study generated fresh insights into a novel TME-related prognostic signature derived from The Cancer Genome Atlas database using integrated bioinformatics analyses. Subsequently, Kaplan–Meier survival analysis, receiver operating characteristic analysis, and univariate and multivariate Cox regression analysis were performed to evaluate and validate the efficacy and the accuracy of the signature in ccRCC prognosis. Furthermore, we discovered that the risk score presented an increased likelihood of correlation with miscellaneous clinicopathological characteristics, natural killer cell-mediated cytotoxicity, immune cell infiltration levels, and immune checkpoint expression. These findings highlighted the notion that the six-gene signature characterized by the TME features may have implications on the risk stratification for personalized and precise immunotherapeutic management.Lu ZhangJianlong LiMengzhao ZhangLu WangTao YangQiuya ShaoXiao LiangMinghai MaNan ZhangMinxuan JingRundong SongJinhai FanJinhai FanFrontiers Media S.A.articlegene signaturetumor microenvironmenttumor-infiltrating immune cellsimmunotherapyclear cell renal cell carcinomaGeneticsQH426-470ENFrontiers in Genetics, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic gene signature
tumor microenvironment
tumor-infiltrating immune cells
immunotherapy
clear cell renal cell carcinoma
Genetics
QH426-470
spellingShingle gene signature
tumor microenvironment
tumor-infiltrating immune cells
immunotherapy
clear cell renal cell carcinoma
Genetics
QH426-470
Lu Zhang
Jianlong Li
Mengzhao Zhang
Lu Wang
Tao Yang
Qiuya Shao
Xiao Liang
Minghai Ma
Nan Zhang
Minxuan Jing
Rundong Song
Jinhai Fan
Jinhai Fan
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
description Clear cell renal cell carcinoma (ccRCC) is widely acknowledged to be extremely sensitive to immunotherapy, emphasizing the tremendous impacts on which the tumor microenvironment (TME) has shown. However, the molecular subgroups characterized by the TME features scarcely serve as the risk stratification guides in clinical practice for survival outcomes and immunotherapy response prediction. This study generated fresh insights into a novel TME-related prognostic signature derived from The Cancer Genome Atlas database using integrated bioinformatics analyses. Subsequently, Kaplan–Meier survival analysis, receiver operating characteristic analysis, and univariate and multivariate Cox regression analysis were performed to evaluate and validate the efficacy and the accuracy of the signature in ccRCC prognosis. Furthermore, we discovered that the risk score presented an increased likelihood of correlation with miscellaneous clinicopathological characteristics, natural killer cell-mediated cytotoxicity, immune cell infiltration levels, and immune checkpoint expression. These findings highlighted the notion that the six-gene signature characterized by the TME features may have implications on the risk stratification for personalized and precise immunotherapeutic management.
format article
author Lu Zhang
Jianlong Li
Mengzhao Zhang
Lu Wang
Tao Yang
Qiuya Shao
Xiao Liang
Minghai Ma
Nan Zhang
Minxuan Jing
Rundong Song
Jinhai Fan
Jinhai Fan
author_facet Lu Zhang
Jianlong Li
Mengzhao Zhang
Lu Wang
Tao Yang
Qiuya Shao
Xiao Liang
Minghai Ma
Nan Zhang
Minxuan Jing
Rundong Song
Jinhai Fan
Jinhai Fan
author_sort Lu Zhang
title Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
title_short Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
title_full Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
title_fullStr Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
title_full_unstemmed Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
title_sort identification of a six-gene prognostic signature characterized by tumor microenvironment immune profiles in clear cell renal cell carcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/fca34c9ea4894a53b07da0f527e1a895
work_keys_str_mv AT luzhang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT jianlongli identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT mengzhaozhang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT luwang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT taoyang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT qiuyashao identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT xiaoliang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT minghaima identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT nanzhang identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT minxuanjing identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT rundongsong identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT jinhaifan identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
AT jinhaifan identificationofasixgeneprognosticsignaturecharacterizedbytumormicroenvironmentimmuneprofilesinclearcellrenalcellcarcinoma
_version_ 1718422085075730432